Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Ridgeback Biotherapeutics announces MHRA clearance to begin human testing of EIDD-2801 in UK for COVID-19

pharmaceutical-business-reviewApril 16, 2020

Tag: Ridgeback Biotherapeutics , MHRA , EIDD-2801 , COVID-19

PharmaSources Customer Service